272 related articles for article (PubMed ID: 25950642)
21. PPI use in the OTC era: who to treat, with what, and for how long?
Inadomi JM; Fendrick AM
Clin Gastroenterol Hepatol; 2005 Mar; 3(3):208-15. PubMed ID: 15765438
[TBL] [Abstract][Full Text] [Related]
22. Treatment of heartburn and acid reflux associated with nausea and vomiting during pregnancy.
Law R; Maltepe C; Bozzo P; Einarson A
Can Fam Physician; 2010 Feb; 56(2):143-4. PubMed ID: 20154244
[TBL] [Abstract][Full Text] [Related]
23. Treating Gastroesophageal Reflux and Heartburn While Breastfeeding.
Anderson PO
Breastfeed Med; 2018 Sep; 13(7):463-464. PubMed ID: 30074826
[No Abstract] [Full Text] [Related]
24. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Hatlebakk JG; Berstad A
Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
[TBL] [Abstract][Full Text] [Related]
25. Alginate therapy is effective treatment for gastroesophageal reflux disease symptoms: a systematic review and meta-analysis.
Leiman DA; Riff BP; Morgan S; Metz DC; Falk GW; French B; Umscheid CA; Lewis JD
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27671545
[TBL] [Abstract][Full Text] [Related]
26. Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis.
Leiman DA; Riff BP; Morgan S; Metz DC; Falk GW; French B; Umscheid CA; Lewis JD
Dis Esophagus; 2017 May; 30(5):1-9. PubMed ID: 28375448
[TBL] [Abstract][Full Text] [Related]
27. The medical management of reflux esophagitis. Role of antacids and acid inhibition.
Sontag SJ
Gastroenterol Clin North Am; 1990 Sep; 19(3):683-712. PubMed ID: 1977703
[TBL] [Abstract][Full Text] [Related]
28. Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease.
Kahrilas PJ; Howden CW; Hughes N
Am J Gastroenterol; 2011 Aug; 106(8):1419-25; quiz 1426. PubMed ID: 21537361
[TBL] [Abstract][Full Text] [Related]
29. Evidence-based treatment recommendations for gastroesophageal reflux disease during pregnancy: A review.
Altuwaijri M
Medicine (Baltimore); 2022 Sep; 101(35):e30487. PubMed ID: 36107559
[TBL] [Abstract][Full Text] [Related]
30. Review article: treatment of mild and severe cases of GERD.
Tytgat GN
Aliment Pharmacol Ther; 2002 Jul; 16 Suppl 4():73-8. PubMed ID: 12047264
[TBL] [Abstract][Full Text] [Related]
31. Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease.
Kung YM; Hsu WH; Wu MC; Wang JW; Liu CJ; Su YC; Kuo CH; Kuo FC; Wu DC; Wang YK
Dig Dis Sci; 2017 Dec; 62(12):3298-3316. PubMed ID: 29110162
[TBL] [Abstract][Full Text] [Related]
32. Review article: the management of heartburn during pregnancy and lactation.
Thélin CS; Richter JE
Aliment Pharmacol Ther; 2020 Feb; 51(4):421-434. PubMed ID: 31950535
[TBL] [Abstract][Full Text] [Related]
33. ABC of the upper gastrointestinal tract: Oesophagus: heartburn.
de Caestecker J
BMJ; 2001 Sep; 323(7315):736-9. PubMed ID: 11576983
[No Abstract] [Full Text] [Related]
34. Short-term treatment of gastroesophageal reflux disease.
van Pinxteren B; Numans ME; Lau J; de Wit NJ; Hungin AP; Bonis PA
J Gen Intern Med; 2003 Sep; 18(9):755-63. PubMed ID: 12950485
[TBL] [Abstract][Full Text] [Related]
35. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
Inadomi JM; McIntyre L; Bernard L; Fendrick AM
Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
[TBL] [Abstract][Full Text] [Related]
36. Management of patients with symptomatic gastroesophageal reflux disease: a primary care perspective.
Fendrick AM
Am J Gastroenterol; 2001 Aug; 96(8 Suppl):S29-33. PubMed ID: 11510767
[TBL] [Abstract][Full Text] [Related]
37. The Clinical Efficacy of a Pure Alginate Formulation (Lamina G) for Controlling Symptoms in Individuals with Reflux Symptoms: A Randomized Clinical Study.
Kim JH; Lee YC; Kim EH; Park JC; Shin SK; Lee SK; Jung DH; Park JJ; Youn YH; Park H
Gut Liver; 2019 Nov; 13(6):642-648. PubMed ID: 30970442
[TBL] [Abstract][Full Text] [Related]
38. HISTORICAL PERSPECTIVE OF GASTROESOPHAGEAL REFLUX DISEASE CLINICAL TREATMENT.
Zaterka S; Marion SB; Roveda F; Perrotti MA; Chinzon D
Arq Gastroenterol; 2019 Aug; 56(2):202-208. PubMed ID: 31460587
[TBL] [Abstract][Full Text] [Related]
39. Exacerbation of gastroesophageal reflux symptoms after discontinuation of proton pump inhibitors is not associated with increased esophageal acid exposure.
Hoshikawa Y; Nikaki K; Sonmez S; Nakagawa K; Yazaki E; Sifrim D; Woodland P
Neurogastroenterol Motil; 2020 Jan; 32(1):e13735. PubMed ID: 31657519
[TBL] [Abstract][Full Text] [Related]
40. Marked increase in proton pump inhibitors use in Australia.
Hollingworth S; Duncan EL; Martin JH
Pharmacoepidemiol Drug Saf; 2010 Oct; 19(10):1019-24. PubMed ID: 20623646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
